Bipartisan senators have introduced a bill to provide $30 million in funding annually to establish psychedelic-focused “centers for excellence” at U.S. Department of Veterans Affairs (VA) facilities, where veterans could receive novel treatment involving substances like psilocybin, MDMA and ibogaine.
As Trump administration officials continue to promote the therapeutic potential of psychedelics, with plans in the works to expand access and research opportunities, Sens. Ruben Gallego (D-AZ) and David McCormick (R-PA) filed the “Innovative Therapies Centers of Excellence Act” this week to help realize that goal.
A House companion version of the bill—sponsored by Congressional Psychedelics Advancing Therapies (PATH) Caucus co-chairs Reps. Lou Correa (D-CA) and Jack Bergman (R-MI)—was introduced last year, but it has not yet advanced in the chamber. The House and Senate measures are substantively identical, with minor formatting differences.
“When I came back from Iraq, I saw my fellow Marines, like so many other veterans, struggle to get the help they needed,” Gallego said in a press release. “Our veterans sacrificed so much for this country. We owe it to them to explore every treatment that can help them heal, including therapeutic uses of psychedelics that may finally break through when others haven’t. I’m proud to
Read full article on Marijuana Moment
